Highly reproducible epidemiological evidence shows that type 2 diabetes (T2D) increases
the risk and rate of progression of Parkinson's disease (PD), and crucially, the repurposing …

The recent validation of the α-synuclein seed amplification assay as a biomarker with high
sensitivity and specificity for the diagnosis of Parkinson's disease has formed the backbone …

Background There is a need for biomarkers to support an accurate diagnosis of Parkinson's
disease (PD). Cerebrospinal fluid (CSF) has been a successful biofluid for finding …

There is growing evidence that patients with type 2 diabetes mellitus (DM) have an
increased risk of developing Parkinson's disease (PD) and share similar dysregulated …

Background Diabetes is associated with incidence and prevalence of Parkinson's disease
(PD). Furthermore, glycated hemoglobin (HbA1c) levels have been linked with motor …

Parkinson's disease (PD) is the second most common neurodegenerative disease after
Alzheimer's disease affecting more than 1% of the population over 65 years old. The …

Progressive age is the single major risk factor for neurodegenerative diseases. Cellular
aging markers during Parkinson's disease (PD) have been implicated in previous studies …

About 10% of the adult population is living with type 2 diabetes mellitus (T2DM) and 1% of
the population over 60 years of age is suffering from Parkinson's disease (PD). A school of …

Abstract Background Alteration in glycosphingolipids (GSLs) in Parkinson's disease (PD)
still needs to be determined. Objectives We evaluated if PD subjects show abnormal GSLs …

Parkinson's disease (PD) is a still incurable neurodegenerative disorder with a highly
complex etiology. While about 10% of cases are associated with single-gene mutations, the …